Genetic variants associated with vein graft stenosis after coronary artery bypass grafting

Heart Surgery Forum

Volumn 18, Issue 1, 2015, Pages E1-E5

  Shah, Asad A ^a   Haynes, Carol ^b   Craig, Damian M ^b   Sebek, Jacqueline ^b   Grass, Elizabeth ^b   Abramson, Karen ^b   Hauser, Elizabeth R ^b   Gregory, Simon G ^b   Kraus, William E ^a,b   Smith, Peter K ^a   Shah, Svati H ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A13; ARID1B PROTEIN; DNA BINDING PROTEIN; MEMBRANE PROTEIN; OX40 LIGAND; PRM2 PROTEIN; RM12 PROTEIN; T LYMPHOCYTE ANTIGEN; TMEM123 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DNA PACKAGING; DNA REPAIR; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE; HEART CATHETERIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; VEIN GRAFT DISEASE; VEIN GRAFT STENOSIS; VEIN OCCLUSION; ARID1B GENE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; GENE; GENE FUNCTION; GENE LOCATION; GENETIC PREDISPOSITION; GRAFT FAILURE; INTRON; PALLD GENE; RISK FACTOR; RMI2 GENE; TMEM123 GENE; TNFSF4 GENE; AGED; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; NORTH CAROLINA; PREVALENCE; SAPHENOUS VEIN; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION;

AGED; CORONARY ARTERY BYPASS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SAPHENOUS VEIN;

EID: 84982757513     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.2015489     Document Type: Article

References (24)

1. Alexander JH, Hafley G, Harrington RA. 2005. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294:2446-54.
2. Bare LA, Morrison AC, Rowland CM, et al. 2007. Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med 9:682-9.
3. Blais A, Dynlacht BD. 2007. E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 19:658-62.
4. Cho C, Willis WD, Goulding EH, et al. 2001. Haploinsufficiency of protamine-1 or -2 causes infertility in mice. Nat Genet 28:82-6.
5. Desai ND, Cohen EA, Naylor CD, Fremes SE. 2004. Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med 351:2302-9.
6. Ellis SG, Chen MS, Jia G, et al. 2007. Relation of polymorphisms in five genes to long-term aortocoronary saphenous vein graft patency. Am J Cardiol 99:1087-9.
7. Goldman S, Sethi GK, Holman W, et al. 2011. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial. JAMA 305:167-74.
8. Grondin CM, Campeau L, Thornton JC, et al. 1989. Coronary artery bypass grafting with saphenous vein. Circulation 79:124-9.
9. Imura A, Hori T, Imada K, et al. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183:2185-95.
10. Jin L, Hastings NE, Blackman BR, Somlyo AV. 2009. Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury. J Muscle Res Cell Motil 30:41-55.
11. Khot UN, Friedman DT, Pettersson G, et al. 2004. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 109:2086-91.
12. Lobato RL, White WD, Mathew JP, et al. 2011. Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation 124(11 Suppl):S143-8.
13. Lytle BW, Loop FD, Taylor PC, et al. 1992. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 103:831-40.
14. Ma F, Zhang C, Prasad KV, et al. 2001. Molecular cloning of porimin, a novel cell surface receptor mediating oncotic cell death. Proc Natl Acad Sci U S A. 98:9778-83.
15. Mälarstig A, Eriksson P, Rose L. 2008. Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem 54:833-40.
16. Manolio TA. 2010. Genomewide association studies and assessment of the risk of disease. N Engl J Med 363:166-76.
17. Muehlschlegel JD, Liu KY, Perry TE, et al. 2010. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation 122(11 Suppl):S60-5.
18. The NCBI handbook [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2002 Oct. Chapter 18, The Reference Sequence (RefSeq) Project. Available from http://www.ncbi.nlm.nih.gov/books/NBK21091/.
19. Online Mendelian Inheritance in Man, OMIM. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), November 20, 2014; http://omim.org/.
20. Ria M, Lagercrantz J, Samnegård A, et al. 2011. A common polymorphism in the promoter region of the TNFSF4 gene is associated with lower allele-specific expression and risk of myocardial infarction. PLoS One 6:e17652.
21. Shah SH, Granger CB, Hauser ER, et al. 2010. Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study. Am Heart J 160:371-379.e2.
22. Shiffman D, Ellis SG, Rowland CM, et al. 2005. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77:596-605.
23. Xu D, Guo R, Sobeck A, et al. 2008. RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev 22:2843-55.
24. Zhang C, Xu Y, Gu J, Schlossman SF. 1998. A cell surface receptor defined by mAb mediates a unique type of cell death similar to oncosis. Proc Natl Acad Sci U S A 95:6290-5.